BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34872672)

  • 1. Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
    Foo CT; Paterson A; Duckworth A; Herre J
    Chest; 2021 Dec; 160(6):e609-e611. PubMed ID: 34872672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.
    Murthy V; Katzman D; Sterman DH
    Clin Respir J; 2019 May; 13(5):272-279. PubMed ID: 30810270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid in viscous malignant mesothelioma pleural effusion.
    Cheah HM; Fitzgerald D; Louw A; Creaney J; Lee YCG
    Respirol Case Rep; 2021 Jan; 9(1):e00694. PubMed ID: 33304592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?
    Agrawal A; Chaddha U; Shojaee S; Maldonado F
    Semin Respir Crit Care Med; 2023 Aug; 44(4):462-467. PubMed ID: 37308112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging the pleural space for anticancer therapies in pleural mesothelioma.
    Blyth KG; Adusumilli PS; Astoul P; Darlison L; Lee YCG; Mansfield AS; Marciniak SJ; Maskell N; Panou V; Peikert T; Rahman NM; Zauderer MG; Sterman D; Fennell DA
    Lancet Respir Med; 2024 Jun; 12(6):476-483. PubMed ID: 38740045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous seeding after ultrasound-guided placement of intrapleural catheter. An unusual complication of the intracavitary palliative treatment of pleural mesothelioma.
    Sartori S; Nielsen I; Trevisani L; Tassinari D; Abbasciano V
    Support Care Cancer; 1999 Sep; 7(5):362-4. PubMed ID: 10483823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma.
    Qureshi M; Thapa B; Muruganandan S
    Heart Lung Circ; 2023 May; 32(5):587-595. PubMed ID: 36925448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
    Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
    Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of malignant pleural mesothelioma.
    Rodríguez Panadero F
    Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.
    Chen D; Li X; Zhao H; Fu Y; Yao F; Hu J; Du N
    Indian J Cancer; 2014 Mar; 51 Suppl 3():e82-5. PubMed ID: 25818740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases.
    Yanagawa H; Sone S; Fukuta K; Nishioka Y; Ogura T
    Jpn J Clin Oncol; 1991 Oct; 21(5):377-83. PubMed ID: 1753419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel intrapleural therapies for malignant diseases.
    Haas AR; Sterman DH
    Respiration; 2012; 83(4):277-92. PubMed ID: 22456231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinous Pleural Fluid With Mesothelioma.
    Kaous M; Bashoura L; Faiz SA
    Arch Bronconeumol; 2021 Aug; 57(8):543. PubMed ID: 35699034
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of malignant pleural mesothelioma with metastasis to the orbit.
    Kubota K; Furuse K; Kawahara M; Ogawara M; Ryu S; Yamamoto S
    Jpn J Clin Oncol; 1996 Dec; 26(6):469-71. PubMed ID: 9001354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion.
    Foo CT; Herre J
    Case Rep Oncol; 2021; 14(1):466-469. PubMed ID: 33976621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RADIO ACTIVE COLLOIDAL GOLD IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSION.
    SHAH JR; WARAWDEKAR MS
    J Assoc Physicians India; 1964 Jan; 12():63-7. PubMed ID: 14102167
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrapleural injection of brucea javanica oil emulsion provided a long-term benefits in patient with malignant pleural effusion from pleural mesothelioma: A case report.
    Zhou H; Wang Q; Jiao L; Bi L; Sang S; Han Y; Gan S; Liu R; A G; Gong Y
    Explore (NY); 2024; 20(1):126-129. PubMed ID: 37286465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transudates in malignancy: still a role for pleural fluid.
    Gonlugur TE; Gonlugur U
    Ann Acad Med Singap; 2008 Sep; 37(9):760-3. PubMed ID: 18989492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
    Chintala NK; Choe JK; McGee E; Bellis R; Saini JK; Banerjee S; Moreira AL; Zauderer MG; Adusumilli PS; Rusch VW
    Front Immunol; 2023; 14():1112960. PubMed ID: 36875061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.